FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 5, 1996
EDITEK, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
1-11394 95-3863205
(Commission File Number) (IRS Employer Identification No.)
1238 Anthony Road
Burlington, North Carolina 27215
(Address of principal executive offices) (Zip Code)
(910) 226-6311
(Registrant's telephone number, including area code)
<PAGE>
Item 5. Other Events.
On June 5, 1996, the Board of Directors of the Registrant formed an
Executive Committee of the Board of Directors comprised of the Registrant's four
outside Directors, Robert J. Beckman, Gene E. Lewis, George W. Masters, and
Samuel C. Powell, Ph.D. The Members of the Executive Committee will serve as the
Office of the Chairman of the Registrant.
James D. Skinner will continue as President and Chief Executive Officer of
the Registrant and will have a special assignment relative to the Registrant's
North Carolina operations. Harry G. McCoy, Pharm.D. will be responsible for
MEDTOX, and Peter J. Heath will continue his responsibilities as Chief Financial
Officer. These three individuals will all report to the Office of the Chairman.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
EDITEK, INC.
Date: June 14, 1996 By:/s/ Peter J. Heath
Name: Peter J. Heath
Title: Vice President of Finance and
Chief Financial Officer
